Extract from the Register of European Patents

EP About this file: EP3399964

EP3399964 - CYCLOSPORINE A TOPICAL COMPOSITIONS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  10.07.2020
Database last updated on 07.04.2026
FormerGrant of patent is intended
Status updated on  11.08.2019
FormerRequest for examination was made
Status updated on  12.10.2018
FormerThe international publication has been made
Status updated on  14.07.2017
Formerunknown
Status updated on  13.01.2017
Most recent event   Tooltip10.07.2020Application deemed to be withdrawnpublished on 12.08.2020  [2020/33]
Applicant(s)For all designated states
Spherium Biomed S.L.
Av. Diagonal 549, 5p.
08029 Barcelona / ES
For all designated states
Bionanoplus, S.L.
Polígono Mocholí
Plaza Cein, 5 - nave B14
31110 Noáin- Navarra / ES
[2018/46]
Inventor(s)01 / SALMAN, Hesham H.A.
Bionanoplus S.L.
Pol. Mocholí
Plaza Cein 5
Nave B14
E-31110 Noáin -Navarra / ES
02 / ESPARZA CATALÁN, Irene
Bionanoplus S.L.
Pol. Mocholí
Plaza Cein 5
Nave B14
E-31110 Noáin -Navarra / ES
03 / SANTOS LOBO, Benjamín
Spherium Biomed S.L.
Joan XXIII, 10
E-08950 Esplugues de Llobregat-Barcelona / ES
04 / LLUCH, Nuria
Spherium Biomed, S.l.
Joan XXIII, 10
E-08950 Esplugues de Llobregat-Barcelona / ES
 [2019/37]
Former [2018/46]01 / SALMAN, Hesham H.A.
Bionanoplus S.L.
Pol. Mocholí
Plaza Cein 5
Nave B14
E-31110 Noáin -Navarra / ES
02 / ESPARZA CATALÁN, Irene
Bionanoplus S.L.
Pol. Mocholí
Plaza Cein 5
Nave B14
E-31110 Noáin (Navarra) / ES
03 / SANTOS LOBO, Benjamín
Spherium Biomed S.L.
Joan XXIII 10
E-08950 Esplugues de Llobregat (Barcelona) / ES
04 / LLUCH, Nuria
Spherium Biomed
S.l.
Joan XXIII
10
E-08950 Esplugues de Llobregat-Barcelona / ES
Representative(s)ABG Intellectual Property Law, S.L.
Avenida de Burgos, 16D
Edificio Euromor
28036 Madrid / ES
[N/P]
Former [2018/46]ABG Intellectual Property, S.L.
Avenida de Burgos, 16D
Edificio Euromor
28036 Madrid / ES
Application number, filing date17700019.703.01.2017
[2018/46]
WO2017EP50059
Priority number, dateEP2016038200104.01.2016         Original published format: EP 16382001
[2018/46]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017118622
Date:13.07.2017
Language:EN
[2017/28]
Type: A1 Application with search report 
No.:EP3399964
Date:14.11.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 13.07.2017 takes the place of the publication of the European patent application.
[2018/46]
Search report(s)International search report - published on:EP13.07.2017
ClassificationIPC:A61K9/107, A61K38/13
[2018/46]
CPC:
A61K38/13 (EP,KR,US); A61K9/1075 (EP,KR,US); A61K47/10 (KR,US);
A61K47/14 (US); A61K47/26 (US); A61K47/32 (KR,US);
A61K9/0014 (KR,US); A61P17/00 (EP,KR,US); A61P17/06 (KR);
A61P37/08 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/46]
TitleGerman:TOPISCHE ZUSAMMENSETZUNGEN MIT CYCLOSPORIN A[2018/46]
English:CYCLOSPORINE A TOPICAL COMPOSITIONS[2018/46]
French:COMPOSITIONS TOPIQUES DE CYCLOSPORINE A[2018/46]
Entry into regional phase06.07.2018National basic fee paid 
06.07.2018Designation fee(s) paid 
06.07.2018Examination fee paid 
Examination procedure06.07.2018Amendment by applicant (claims and/or description)
06.07.2018Examination requested  [2018/46]
06.07.2018Date on which the examining division has become responsible
12.08.2019Communication of intention to grant the patent
03.01.2020Application deemed to be withdrawn, date of legal effect  [2020/33]
24.01.2020Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2020/33]
Fees paidRenewal fee
13.12.2018Renewal fee patent year 03
27.01.2020Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A] WO2014189251  (TAEJOON PHARM CO LTD et al.)
 [A] US5962017  (HAUER BIRGIT et al.)
 [A] WO0128520  (VESIFACT AG et al.)
 [A] US2007015691  (CHANG JAMES N et al.)
by applicantUS8642556
 US8629111
 US8618064
 US8633162
 US8648048
 US8685930
 US5891846
   AMOR ET AL., J. AM. ACAD. DERMATOL., vol. 63, 2010, pages 925 - 946
   AMOR ET AL., J. AM. ACAD. DERMATOL.,, vol. 63, 2010, pages 925 - 946
   KOVALIK ET AL., THE VETERINARY JOURNAL, vol. 193, 2012, pages 317 - 325
   PALMEIRO, VET. CLIN. SMALL ANIM., vol. 43, 2013, pages 154 - 171
   CARIDI ET AL.: "Topical Calcineurin Inhibitors in the Treatment of Vitiligo in Bitiligo - Management and Therapy", 2001
   GODDERERIS C. ET AL., INTERNATIONAL JOURNAL OF PHARMACEUTICS, vol. 312, 2006, pages 187 - 195
   GRIFFIN, JOURNAL OF THE SOCIETY OF COSMETIC CHEMISTS, vol. 1, 1949, pages 311 - 326
   "Handbook of pharmaceutical excipients", 2009, THE PHARMACEUTICAL PRESS
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.